
KardioLytix is a real-time data analytics tool for the
measurement and reporting of outcomes-based health
and predictive or future risk assessment, as well as
decision making.
At BrandMed, we believe that by combining scientific
literature, expert knowledge and state-of-the-art machine
learning with data analytics, better decisions can be made
within the construct of the current healthcare environment
and its challenges.
With contextual data expansion, the KardioLytix system has
the ability to transition to the automated calculation of risk
of a wide range of future healthcare outcomes, such as:
- Identifying patients presenting the greatest healthcare risks during a future period, often within the following 12, 24 or 36 months
- Identifying patients most at risk of developing chronic comorbidities
- Identifying patients most at risk of a deteriorating health status
- Identifying patients most at risk of specific adverse health events, for example, a cardiovascular event or invasive back surgery
- Predicting patients most at risk of unplanned hospital admissions, readmissions, or emergency care visits
- Predicting the mortality risk of patients in hospital
- Predicting the risk of complications for patients in hospital